Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about SNY

Recent news which mentions SNY

...

24 25 26 27 28 29 30 31 Next >

AstraZeneca-Sanofi's Nirsevimab Shows 75% Efficacy Against RSV In Healthy Infants

March 03, 2022

Viatris Just Snagged a Major FDA Approval

March 03, 2022

36 Stocks To Watch After Biden's First State of The Union Address

March 02, 2022

Sanofi Taps Adagene's 'Masking' Tech In Over $2.5B Immuno-Oncology Pact

March 02, 2022

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi

March 02, 2022

Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates

March 02, 2022

Canada Approves First Plant-Based COVID-19 Vaccine

February 25, 2022

BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market

February 24, 2022

Why Moderna Stock Is Falling Today

February 23, 2022

Sanofi-GSK Prepare Regulatory Filings For COVID-19 Vaccine After Booster Data

February 23, 2022

2 Green Flags for Novavax's Future

February 23, 2022

WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths

February 23, 2022

Sanofi, GSK to seek approval for Covid-19 vaccine after positive trial results

February 23, 2022

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow

February 20, 2022

GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women

February 18, 2022

The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings

February 18, 2022

Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial

February 18, 2022

Hopeful Golden Cross Forms On Sanofi's Chart

February 17, 2022

3 Desirable Drug Stocks With Very Promising Pipelines

February 16, 2022

3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch

February 16, 2022

Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis

February 10, 2022

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly

February 10, 2022

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More

February 06, 2022

Could This New Indication Create a Blockbuster for Pfizer?

February 05, 2022

Sanofi (SNY) Q4 2021 Earnings Call Transcript

February 04, 2022

Sanofi: Q4 Earnings Insights

February 04, 2022

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures

February 04, 2022

Sanofi Records Q4 Topline, Bottomline Growth As Blockbuster Eczema Drug Soars

February 04, 2022

Earnings Scheduled For February 4, 2022

February 04, 2022

A Preview Of Sanofi's Earnings

February 03, 2022

...

24 25 26 27 28 29 30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.